Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  ObesityPublic HealthIssue 729

AACE Announces a New Medically-Actionable Diagnosis of Obesity

An advanced framework for a new diagnostic approach to obesity was announced last week by the American Association of Clinical Endocrinologists (AACE) at their 23rd Scientific and Clinical Congress.... 

Advertisement

An emergent concept from the Consensus Conference on Obesity, convened by AACE and the American College of Endocrinology (ACE) in March 2014, was that the current diagnostic definition of obesity, which relied on an anthropomorphic measure of body mass index (BMI), needed to be updated. BMI alone does not indicate how weight gain might be affecting the health of individual patients, and multiple stakeholders at the Consensus Conference saw this as a major obstacle to concerted action in combatting obesity.

The new obesity definition and diagnostic strategy is actionable, medically-meaningful and adds value to the health-promoting effects of weight loss.

Dr. W. Timothy Garvey, Chair of the AACE/ACE Consensus Conference on Obesity and Obesity Scientific Committee and author of the AACE/ACE Obesity Consensus Statement, added that, "This approach addresses a problem of diagnostic uncertainty and is the first step in removing the impediment for concerted and comprehensive action among health care professionals, health care systems, regulators, payers, and employers."

In 2011, AACE/ACE declared obesity as a chronic disease as did the American Medical Association in June 2013.

The new approach does not simply depend upon BMI alone, but also the impact of weight gain on health. A four-step approach is recommended for all patients: screening using BMI with adjustments for ethnic differences, clinical evaluation for the presence of obesity-related complications using a checklist, staging for the severity of complications using complication-specific criteria, and selection of prevention and/or intervention strategies targeting specific complications as guided by the AACE/ACE obesity management algorithm.

The next steps will be to obtain broad input and recommendations regarding the framework for the new diagnostic approach from participants at the Consensus Conference on Obesity. The goal is to assure broad-based acceptance, translation, and implementation of the diagnosis that will support concerted action around a rational and comprehensive plan to prevent and treat obesity.

Presented at the 2015 Meeting of the American Association of Clinical Endocrinologists. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  ObesityPublic HealthIssue 729

Past five issues: Diabetes Clinical Mastery Series Issue 219 | SGLT-2 Inhibitors Special Edition December 2014 | Issue 759 | Diabetes Clinical Mastery Series Issue 218 | GLP-1 Special Editions December 2014 |

2014 Most Popular Articles:

New Guidelines for Doctors to Treat Diabetes
Posted December 12, 2014
Handbook of Diabetes, 4th Ed., Excerpt #20: Foot Problems in Diabetes
Posted November 29, 2014
Why Are Up to 20% Type 2's Nonresponsive to Exercise?
Posted December 05, 2014
Is Type 2 Diabetes an Inflammatory Disease?
Posted November 21, 2014
Handbook of Diabetes, 4th Ed., Excerpt #19: Macrovascular Disease in Diabetes
Posted November 23, 2014
Carbs Associated with Higher Diabetes and Heart Disease Risk Factor
Posted December 05, 2014
Any Pain Medication Said Effective When Treating Diabetic Nerve Pain
Posted November 21, 2014
Knowledge of Onset, Peak, and Duration of Action of Meds Prevents a Trip to the ER
Posted November 24, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014
Link between Free Fatty Acids and Acute MI, Type 2 Diabetes
Posted November 21, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
For your prediabetes patients who can't lower their blood glucose with lifestyle changes, do you prescribe GLP-1s or SGLT-2s?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control